top of page
The
Promise of
Interleukin-2
Therapy
4 - 7 Sept. 2024
for autoimmune and inflammatory diseases, allergy, transplantation and cancer
Auditorium
Centre international de Conférences Sorbonne Université
4 place Jussieu, Patio
75005 - Paris, France
*To submit before June 15th, 2024 to il2.congress.2024@gmail.com
2024 Preliminary Agenda
Wed. 4
Thu. 5
Fri. 6
Sat. 7
6.00 pm
8.00 pm
9.00 am
Opening Session
Keynote Lectures
Session I - On mechanistic aspects: IL-2, receptors and signaling
Welcome Reception
10.30 am
Coffee Break
11.00 am
Session II - Lessons from current clinical trials with native IL-2
1.00 pm
Lunch & Posters
2.00 pm
Session III - On mechanistic aspects: Treg and tissue regeneration
3.30 pm
Coffee Break
4.30 pm
Session IV – Treg and IL2 in brain disorders
9.00 am
9.00 am
Session V – immunotherapy of brain disorders
10.30 am
Coffee Break
1.00 pm
Lunch & Posters
2.00 pm
Session VII - IL-2 and Treg cell therapies (1)
4.00 pm
Session VIII - IL-2 and Treg cell therapies (2)
5.30 pm
Drinks & Posters
4.00 pm
Coffee Break
Session IX - IL-2 in cancer therapy
11.00 am
Coffee Break
11.30 am
Session X - Novel IL-2s, vectorisation and combination therapies
1.30 pm
END OF THE MEETING
6.30 pm
7.00 pm
End of day
End of day
11.00 am
Session VI – Treg targeted IL-2 muteins in clinical trials
Schedule
Confirmed Speakers
(by alphabetical order)
Ron Germain, Jonathan Kipnis, David Klatzmann, Zhanguo Li, Adrian
Liston, Diane Mathis, Thomas Malek, Alexander Marson,
Aleksander Rudensky, Jamie Spangler, Shimon Sakaguchi, Qizhi
Tang, Benjamin Youngblood
Confirmed Speakers
Organizers
International Committee
Laurie Dempsey
Shimon Sakaguchi
Lucy Walker
bottom of page